Animalcare Group

Animalcare combines good financial performance with a very sensible strategy and a strong management team. The company has made several value-enhancing acquisitions, such as an equine health business in Australia and it has sold of some non-core assets to generate cash and keep the strategic focus.

Its key products are in high demand in rapidly growing areas such as dental care for pets. The company is committed to investing in new product development and is well-placed for solid long-term growth.

Animalcare supplies pharmaceuticals for animal health. Its medicines typically rely on established active ingredients and animal testing is conducted only where legally required.

However, all testing is outsourced to third parties, with potentially limited public disclosure of oversight practices, raising ethical concerns relating to animal welfare.

While suppliers are required to comply with Good Manufacturing Practice standards, Animalcare provides limited transparency into its supply chain structure or sourcing origins. This reduces visibility into possible risks. 
Environmental risks include potential land and water contamination from veterinary products, though no specific incidents have been reported.